Mayo Clinic Comprehensive Cancer Center experts highlight breast cancer research that may reduce or eliminate the need for chemotherapy and endocrine treatments and may allow for shorter and less ...

Novartis has secured European Commission approval for Kisqali® (ribociclib) in combination with endocrine therapy (ET) as an ...

Immunome, Inc. (NASDAQ:IMNM – Get Free Report) gapped up prior to trading on Monday after an insider bought additional shares in the company. The stock had previously closed at $9.82, but opened at ...

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from ...